Homocystinuria treated with pyridoxine

Area of Science:

• Ophthalmology
• Medical Genetics
• Biochemistry

Background:

• Homocystinuria (HCU) is a rare metabolic disorder.
• Lens luxation is a key ocular manifestation of HCU.
• Pyridoxine is a potential treatment for HCU.

Observation:

• Four cases of HCU with lens luxation were studied.
• Patients showed positive response to pyridoxine treatment based on plasma amino acid levels.
• Lens luxation progression occurred in one patient despite treatment.

Findings:

• Scanning electron microscopy revealed structural abnormalities in the lens zonules and capsule.
• Discontinuation of pyridoxine treatment was associated with adverse outcomes, including death.
• The silver-nitroprusside test is a specific diagnostic tool for HCU.

Implications:

• Early diagnosis of HCU by ophthalmologists is vital.
• Timely pyridoxine treatment may reduce severe complications like thromboembolism.
• Ophthalmologists play a critical role in identifying HCU through lens examination and specific testing.